Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260428069192N4Phase 3Completed
Phase 3, randomised, double-blind trial comparing Propofol alone with Propofol + ketamine (2 arms). Primary endpoints: Extubation quality, Heart rate and 3 more. Started Jul 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260428069192N4.